Concepedia

Publication | Closed Access

Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry

65

Citations

18

References

2020

Year

Abstract

After 52 weeks, ustekinumab demonstrated effectiveness in inducing clinical and endoscopic remission in patients with refractory CD.

References

YearCitations

Page 1